These Mre11ATLD1/ATLD1 mice contain a mutation in the Mre11 gene, similar to that found in humans with ataxia-telangiectasia like disorder.
John Petrini, Memorial Sloan-Kettering Cancer Center
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Humanized sequence) | Mre11a | MRE11A homolog A, double strand break repair nuclease |
These Mre11ATLD1/ATLD1 mice contain an A to T point mutation at nucleotide 1894, corresponding to human codon 633, of the meiotic recombination 11 homolog A (Mre11) gene. MRE11 is a component of a trimeric protein complex also containing Nbs1 and Rad50 which is involved in DNA double-strand break repair, cell cycle checkpoint activation, telomere maintenance, and meiotic recombination. This mutation introduces a premature stop codon, resulting in the truncation of 75 amino acids which produces a hypomorphic protein. This mutation is commonly found in human ataxia-telangiectasia like disorder (A-TLD) and Nijmegen Breakage Syndrome (NBS). A-TLD is characterized by defects in movement, coordination, and immune responses due to chromosomal instability. NBS is characterized by short stature, microcephaly, distinctive facial features, recurrent respiratory tract infections, an increased risk of cancer, and intellectual disability. Homozygous Mre11ATLD1/ATLD1 females have severely reduced fertility, with decreased embryonic viability due to genome instability and cell cycle checkpoint defects. Homozygous males are viable and fertile. These mice, and cells derived from these mice, exhibit DNA double strand break repair defects, cell-cycle checkpoint defects, and chromosomal instability. These mice are not prone to malignancy including lymphomagenesis.
A targeting construct was designed to introduce an A to T point mutation at nucleotide 1894, corresponding to human codon 633, resulting in a premature STOP codon in the meiotic recombination 11 homolog A (Mre11) gene, commonly found in human ataxia-telangiectasia like disorder (A-TLD). A neomycin resistance cassette was placed downstream of the mutation. This targeting construct was electroporated into 129S7/SvEvBrd-Hprtb-m2-derived AB2.2 embryonic stem (ES) cells and correctly targeted ES cells were injected into C57BL/6 blastocysts. The resulting chimeric males were bred to C57BL/6 females. These Mre11ATLD1/ATLD1 mice were maintained on a mixed background. Upon arrival at The Jackson Laboratory, mutant mice were bred to C57BL/6J mice (Stock No. 000664) for at least one generation to establish the colony.
Allele Name | targeted mutation 1, John H J Petrini |
---|---|
Allele Type | Targeted (Humanized sequence) |
Allele Synonym(s) | Mre11ATLD1 |
Gene Symbol and Name | Mre11a, MRE11A homolog A, double strand break repair nuclease |
Gene Synonym(s) | |
Strain of Origin | 129S7/SvEvBrd-Hprtb-m2 |
Chromosome | 9 |
Molecular Note | An A-to-T transversion point mutation was engineered at nucleotide 1894 of the coding sequence to recapitulate a nonsense mutation identified in human patients (codon 633). This mutation results in the truncation of 75 amino acids. |
When maintaining a live colony, heterozygous females may be bred to homozygous males. Homozygous females are extremely subfertile.
When using the B6;129S7-Mre11atm1Jpt/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #024172 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous for Mre11a<tm1Jpt> |
Frozen Mouse Embryo | B6;129S7-Mre11a<tm1Jpt>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6;129S7-Mre11a<tm1Jpt>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6;129S7-Mre11a<tm1Jpt>/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | B6;129S7-Mre11a<tm1Jpt>/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.